Minodronic acid hydrate

Overview

Minodronic acid (YM-529) hydrate is an FPP synthase inhibitor with an IC 50 of 3 nM, and also an antagonist of P2X2/3 receptors with an IC 50 of 62.7 μM. Minodronic acid hydrate induces tumor cell apoptosis and inhibits cell growth. Minodronic acid hydrate also suppresses bone resorption. Minodronic acid hydrate can be used in research related to osteoporosis and cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > P2X Receptor | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-16322A
• CAS No.: 155648-60-5
• Molecular Formula: C9H14N2O8P2
• Molecular Weight: 340.16
• Purity: 99.67%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source